This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of California. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Zhiqun Tan: Innovator in Huntington's Disease Diagnosis and Treatment
Introduction
Zhiqun Tan, based in Irvine, CA, is an innovative inventor known for his significant contributions to the field of medical diagnostics. With a focus on Huntington's disease, he has developed groundbreaking technology aimed at improving the diagnosis and monitoring of this neurodegenerative condition.
Latest Patents
Zhiqun Tan holds one notable patent titled "Diagnostic and Monitoring System for Huntington's Disease." This invention introduces assays designed to identify Huntington's disease and track the progression and severity of conditions associated with the variant Huntingtin protein (Httn). Notably, the invention also includes methods for predicting the onset of symptoms, providing invaluable insights for both patients and healthcare providers. Additionally, it offers a pathway for identifying potential drug treatments for Huntington's disease.
Career Highlights
Zhiqun Tan is currently affiliated with the University of California, where he applies his expertise in creating solutions that advance healthcare and improve the quality of life for those impacted by Huntington's disease. His work exemplifies a commitment to scientific research and innovation.
Collaborations
Throughout his career, Tan has collaborated with esteemed colleagues, including Steven Potkin and Leslie Thompson. Together, they push the boundaries of research, sharing knowledge and insights that drive advancements in understanding and treating Huntington's disease.
Conclusion
Zhiqun Tan’s contributions to medical diagnostics represent a significant advancement in the fight against Huntington's disease. His dedication to innovation not only aids in the identification of the disease but also has the potential to transform the treatment landscape, offering hope to many affected by this challenging condition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
